ABSI
Price
$2.90
Change
+$0.10 (+3.57%)
Updated
Jan 17 closing price
Capitalization
333.08M
60 days until earnings call
ACRV
Price
$5.78
Change
+$0.23 (+4.14%)
Updated
Jan 17 closing price
Capitalization
179.97M
67 days until earnings call
Ad is loading...

ABSI vs ACRV

Header iconABSI vs ACRV Comparison
Open Charts ABSI vs ACRVBanner chart's image
Absci
Price$2.90
Change+$0.10 (+3.57%)
Volume$2.52M
Capitalization333.08M
Acrivon Therapeutics
Price$5.78
Change+$0.23 (+4.14%)
Volume$79.5K
Capitalization179.97M
ABSI vs ACRV Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. ACRV commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and ACRV is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (ABSI: $2.90 vs. ACRV: $5.78)
Brand notoriety: ABSI and ACRV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 66% vs. ACRV: 145%
Market capitalization -- ABSI: $333.08M vs. ACRV: $179.97M
ABSI [@Biotechnology] is valued at $333.08M. ACRV’s [@Biotechnology] market capitalization is $179.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileACRV’s FA Score has 1 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • ACRV’s FA Score: 1 green, 4 red.
According to our system of comparison, ACRV is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 4 TA indicator(s) are bullish while ACRV’s TA Score has 5 bullish TA indicator(s).

  • ABSI’s TA Score: 4 bullish, 3 bearish.
  • ACRV’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ACRV is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а +1.58% price change this week, while ACRV (@Biotechnology) price change was +5.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

ABSI is expected to report earnings on May 20, 2025.

ACRV is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($333M) has a higher market cap than ACRV($180M). ABSI YTD gains are higher at: 10.687 vs. ACRV (-3.987). ABSI (-83.27M) and ACRV (-84.45M) have comparable annual earnings (EBITDA) . ACRV has more cash in the bank: 187M vs. ABSI (127M). ACRV has less debt than ABSI: ACRV (4.01M) vs ABSI (12M). ABSI has higher revenues than ACRV: ABSI (4.21M) vs ACRV (0).
ABSIACRVABSI / ACRV
Capitalization333M180M185%
EBITDA-83.27M-84.45M99%
Gain YTD10.687-3.987-268%
P/E RatioN/AN/A-
Revenue4.21M0-
Total Cash127M187M68%
Total Debt12M4.01M299%
TECHNICAL ANALYSIS
Technical Analysis
ABSIACRV
RSI
ODDS (%)
N/A
Bullish Trend 11 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
81%
Momentum
ODDS (%)
Bullish Trend 11 days ago
90%
Bearish Trend 11 days ago
89%
MACD
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 11 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
87%
Bullish Trend 11 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
85%
Bearish Trend 11 days ago
81%
Advances
ODDS (%)
Bullish Trend 13 days ago
89%
Bullish Trend 13 days ago
89%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 11 days ago
89%
Aroon
ODDS (%)
Bullish Trend 11 days ago
90%
Bearish Trend 11 days ago
80%
View a ticker or compare two or three
Ad is loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TLARX11.370.09
+0.80%
Transamerica Large Core ESG R
FMDGX34.350.22
+0.64%
Fidelity Mid Cap Growth Index
RYRHX54.700.21
+0.39%
Rydex Russell 2000 H
MSOIX39.360.13
+0.33%
NYLI WMC Enduring Capital Class I
OAYBX36.450.09
+0.25%
Oakmark Equity and Income Advisor

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
+4.14%
ALLR - ACRV
48%
Loosely correlated
+1.94%
CDXS - ACRV
39%
Loosely correlated
+1.63%
ABSI - ACRV
37%
Loosely correlated
+3.57%
DAWN - ACRV
33%
Poorly correlated
+1.13%
DNLI - ACRV
32%
Poorly correlated
+1.20%
More